Mignon F, Siohan P, Legallicier B, Khayat R, Viron B, Michel C
Service de Néphrologie, Hôpital Tenon Paris, France.
Nephrol Dial Transplant. 1995;10 Suppl 6:55-9. doi: 10.1093/ndt/10.supp6.55.
The particularity of geriatric medicine and the lack of information due to the fact that geriatric nephrology dates back only 10 years explains why the management of chronic uraemia among the elderly presents itself as a succession of difficult dilemmas. (1) Should causes of chronic renal failure be systematically determined and treated? Risk-benefit assessments of the investigations and treatments involved in preventing or slowing down the evolution to end-stage renal disease (ESRD) are required to answer this question. (2) In cases of ESRD, should dialysis always be considered? The fact that life expectancy is limited for the aged does not justify depriving them of treatment. Nevertheless, in some borderline situations, conservative treatment may be preferable. (3) When should dialysis be started? Currently the mortality before the 90th day of dialysis is very high among elderly patients. To improve results it is probably necessary to determine appropriate criteria for starting treatment before complications occur. (4) What is the best method for the first treatment? There is much controversy about the respective advantages of haemodialysis and peritoneal dialysis. The choice depends on the individual's medical and social conditions. (5) Should dialysis treatment be stopped, and, if so, in this case, when? The large acceptance rate of elderly patients for dialysis implies that withdrawal of treatment must sometimes be considered. Fears linked to this dilemma probably explain why some physicians choose to exclude elderly patients from dialysis. It seems to us more ethical to treat this group of patients and assume responsibility for stopping treatment should it be necessary.
老年医学的特殊性以及老年肾脏病学仅发展了10年导致信息匮乏,这就解释了为何老年慢性尿毒症的管理呈现出一系列艰难的困境。(1)是否应系统地确定并治疗慢性肾衰竭的病因?要回答这个问题,需要对预防或减缓疾病进展至终末期肾病(ESRD)所涉及的检查和治疗进行风险效益评估。(2)对于ESRD患者,是否总是应考虑透析?老年人预期寿命有限这一事实并不能成为剥夺他们治疗的理由。然而,在一些临界情况下,保守治疗可能更可取。(3)何时开始透析?目前老年患者透析第90天前的死亡率非常高。为改善治疗效果,可能有必要在并发症出现前确定开始治疗的合适标准。(4)首次治疗的最佳方法是什么?血液透析和腹膜透析各自的优势存在诸多争议。选择取决于个体的医疗和社会状况。(5)是否应停止透析治疗,如果是,那么何时停止?老年患者对透析的接受率很高,这意味着有时必须考虑停止治疗。与这一困境相关的担忧可能解释了为何一些医生选择将老年患者排除在透析之外。在我们看来,治疗这组患者并在必要时承担停止治疗的责任更符合伦理。